Psilocybin mushrooms for psychological and existential distress
Ryan Patchett-Marble, Sean O’sullivan, Sayali Tadwalkar, Emma Hapke
Canadian Family Physician November 1, 2022 DOI: 10.46747/cfp.6811823 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Psilocybin End-of-life distress |
| Keywords | The renaissance Existentialism Distress Hallucinogen Data science |
| Citations | 13 |
| Key points | Interest in the medical use of psychedelic compounds has exploded after decades of dormancy, primarily under medical researchers, and recent Canadian legal precedents have allowed some access. |
Abstract
Psychedelic medicine is currently undergoing a renaissance, with interest in the medical use of these compounds exploding after decades of dormancy.[1][1] This has occurred primarily under the purview of medical researchers; however, recent legal precedents in Canada have allowed some access to
Citations in the library
Cited by 11
- Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis World Journal of Clinical Oncology July 16, 2024
- Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review. Palliative & Supportive Care April 22, 2025
- Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis. Journal of Palliative Medicine October 1, 2023
- Current practices in managing end-of-life existential suffering. Current opinion in supportive and palliative care June 1, 2023
- What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative study. Palliative & Supportive Care October 1, 2024
and 6 more in the library
Cites 10
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer Journal of Psychopharmacology January 9, 2020
and 5 more in the library